French enforcer agrees to minority stake divestment in medical lab deal
France’s Competition Authority has conditionally approved medical lab operator Inovie's purchase of a rival, in a decision that marks the first time it has found that a buyer’s acquisition of majority and minority stakes in two separate companies will harm competition.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.